Methylseleninic acid superactivates p53-senescence cancer progression barrier in prostate lesions of pten-knockout mouse

Keyphrases

• Pten 100%
• Senescence 100%
• Cancer Progression 100%
• Prostate Lesions 100%
• Methylseleninic Acid 100%
• High Grade Prostatic Intraepithelial Neoplasia (HGPIN) 50%
• Androgen Receptor 37%
• Oncogenic Signaling 25%
• Acid Treatment 25%
• Cellular Changes 12%
• Advanced Prostate Cancer 12%
• P53 Pathway 12%
• Metabolism Activity 12%
• Akt Phosphorylation 12%
• Molecular Changes 12%
• Senescence-associated 12%
• β-Galactosidase (β-Gal) 12%
• P53 Expression 12%
• Selenium Forms 12%
• P21Cip1 12%
• Protein Kinase B/Akt 12%
• Phosphatidylinositol 3 12%
• Superactivation 12%
• Tumor Suppressor 12%
• Methylselenol 12%
• Tumor Weight 12%
• Littermate 12%
• Prostate Epithelium 12%
• Cell Proliferation Index 12%
• Preventive Efficacy 12%
• Kinase Protein 12%
• Precancerous Lesions 12%
• Cancer Chemoprevention 12%
• Anticancer Activity 12%
• Tensin Homolog 12%
• Cellular Senescence 12%
• Ki-67 12%
• Invasive Carcinoma 12%

Medicine and Dentistry

• Protein P53 100%
• Cancer Growth 100%
• High-Grade Prostatic Intraepithelial Neoplasia 66%
• Androgen Receptor 50%
• Selenomethionine 16%
• Phosphatase 16%
• Prostate Epithelium 16%
• Antineoplastic Activity 16%
• Tensin 16%
• Precursor 16%
• Precancerous Condition 16%
• Chemoprevention 16%
• Tumor Suppressor Protein 16%
• Cellular Senescence 16%
• Galactosidase 16%
• Invasive Carcinoma 16%
• Protein Kinase B 16%
• Phosphatidylinositol 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Protein P53 100%
• Knockout Mouse 100%
• Cancer Growth 100%
• Prostatic Intraepithelial Neoplasia 66%
• Androgen Receptor 50%
• Precancer 16%
• Selenomethionine 16%
• Phosphatidylinositol 16%
• Phosphatase 16%
• Invasive Carcinoma 16%
• Tumor Suppressor Protein 16%
• Galactosidase 16%
• Tensin 16%